Rating History for Benitec BioPharma (BNTC) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for BNTC
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/10/2026 Debjit Chattopadhyay Downgrade Neutral
(Buy)		 N/A
(N/A)		 10.81
(12.78)		 18.22% Details